Literature DB >> 21406292

Intestinal phosphate transport.

Yves Sabbagh1, Hector Giral, Yupanqui Caldas, Moshe Levi, Susan C Schiavi.   

Abstract

Phosphate is absorbed in the small intestine by a minimum of 2 distinct mechanisms: paracellular phosphate transport which is dependent on passive diffusion, and active transport which occurs through the sodium-dependent phosphate cotransporters. Despite evidence emerging for other ions, regulation of the phosphate-specific paracellular pathways remains largely unexplored. In contrast, there is a growing body of evidence that active transport through the sodium-dependent phosphate cotransporter, Npt2b, is highly regulated by a diverse set of hormones and dietary conditions. Furthermore, conditional knockout of Npt2b suggests that it plays an important role in maintenance of phosphate homeostasis by coordinating intestinal phosphate absorption with renal phosphate reabsorption. The knockout mouse also suggests that Npt2b is responsible for the majority of sodium-dependent phosphate uptake. The type-III sodium-dependent phosphate transporters, Pit1 and Pit2, contribute to a minor role in total phosphate uptake. Despite coexpression along the apical membrane, differential responses of Pit1 and Npt2b regulation to chronic versus dietary changes illustrates another layer of phosphate transport control. Finally, a major problem in patients with CKD is management of hyperphosphatemia. The present evidence suggests that targeting key regulatory pathways of intestinal phosphate transport may provide novel therapeutic approaches for patients with CKD.
Copyright © 2011 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21406292      PMCID: PMC3071860          DOI: 10.1053/j.ackd.2010.11.004

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  72 in total

Review 1.  Tight junction proteins.

Authors:  L González-Mariscal; A Betanzos; P Nava; B E Jaramillo
Journal:  Prog Biophys Mol Biol       Date:  2003-01       Impact factor: 3.667

2.  The role of an intracellular cysteine stretch in the sorting of the type II Na/phosphate cotransporter.

Authors:  Gavin S McHaffie; Chris Graham; Beate Kohl; Ursula Strunck-Warnecke; Andreas Werner
Journal:  Biochim Biophys Acta       Date:  2007-05-23

3.  Comparative aspects of gastrointestinal phosphorus metabolism.

Authors:  G Breves; B Schröder
Journal:  Nutr Res Rev       Date:  1991-01       Impact factor: 7.800

4.  Expression of renal and intestinal Na/Pi cotransporters in the absence of GABARAP.

Authors:  Sonja C Reining; Annette Liesegang; Heinrich Betz; Jürg Biber; Heini Murer; Nati Hernando
Journal:  Pflugers Arch       Date:  2010-03-31       Impact factor: 3.657

Review 5.  Identification and characterization of a widely expressed phosphate transporter/retrovirus receptor family.

Authors:  M P Kavanaugh; D Kabat
Journal:  Kidney Int       Date:  1996-04       Impact factor: 10.612

6.  Site of vitamin D action in chick intestine.

Authors:  S Hurwitz; A Bar
Journal:  Am J Physiol       Date:  1972-03

7.  Extended release nicotinic acid - a novel oral agent for phosphate control.

Authors:  Krishnaswamy Sampathkumar; Manickam Selvam; Yesudas Santhakumari Sooraj; Sankaran Gowthaman; Rajappan Nair Prabha Ajeshkumar
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

8.  Role of rat sodium/phosphate cotransporters in the cell membrane transport of arsenate.

Authors:  Ricardo Villa-Bellosta; Víctor Sorribas
Journal:  Toxicol Appl Pharmacol       Date:  2008-06-10       Impact factor: 4.219

9.  Analysis of segmental phosphate absorption in intact rats. A compartmental analysis approach.

Authors:  L H Kayne; D Z D'Argenio; J H Meyer; M S Hu; N Jamgotchian; D B Lee
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

10.  Matrix extracellular phosphoglycoprotein inhibits phosphate transport.

Authors:  Joanne Marks; Linda J Churchill; Edward S Debnam; Robert J Unwin
Journal:  J Am Soc Nephrol       Date:  2008-11-12       Impact factor: 10.121

View more
  39 in total

Review 1.  Role of αKlotho and FGF23 in regulation of type II Na-dependent phosphate co-transporters.

Authors:  Ming Chang Hu; Mingjun Shi; Orson W Moe
Journal:  Pflugers Arch       Date:  2018-12-01       Impact factor: 3.657

Review 2.  Dietary Phosphorus Intake and the Kidney.

Authors:  Alex R Chang; Cheryl Anderson
Journal:  Annu Rev Nutr       Date:  2017-06-14       Impact factor: 11.848

3.  Intestinal phosphate absorption: The paracellular pathway predominates?

Authors:  Matthew Saurette; R Todd Alexander
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-14

Review 4.  Novel developments in differentiating the role of renal and intestinal sodium hydrogen exchanger 3.

Authors:  Jessica A Dominguez Rieg; Samantha de la Mora Chavez; Timo Rieg
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-10-12       Impact factor: 3.619

5.  A physiologic-based approach to the evaluation of a patient with hyperphosphatemia.

Authors:  David E Leaf; Myles Wolf
Journal:  Am J Kidney Dis       Date:  2012-08-30       Impact factor: 8.860

Review 6.  Regulation of renal phosphate handling: inter-organ communication in health and disease.

Authors:  Sawako Tatsumi; Atsumi Miyagawa; Ichiro Kaneko; Yuji Shiozaki; Hiroko Segawa; Ken-Ichi Miyamoto
Journal:  J Bone Miner Metab       Date:  2015-08-22       Impact factor: 2.626

7.  Effect of Npt2b deletion on intestinal and renal inorganic phosphate (Pi) handling.

Authors:  Kayo Ikuta; Hiroko Segawa; Shohei Sasaki; Ai Hanazaki; Toru Fujii; Aoi Kushi; Yuka Kawabata; Ruri Kirino; Sumire Sasaki; Miwa Noguchi; Ichiro Kaneko; Sawako Tatsumi; Otoya Ueda; Naoko A Wada; Hiromi Tateishi; Mami Kakefuda; Yosuke Kawase; Shuichi Ohtomo; Yasuhiro Ichida; Akira Maeda; Kou-Ichi Jishage; Naoshi Horiba; Ken-Ichi Miyamoto
Journal:  Clin Exp Nephrol       Date:  2017-11-11       Impact factor: 2.801

Review 8.  Hyperphosphataemia: treatment options.

Authors:  Fabio Malberti
Journal:  Drugs       Date:  2013-05       Impact factor: 9.546

9.  Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability.

Authors:  Andrew J King; Matthew Siegel; Ying He; Baoming Nie; Ji Wang; Samantha Koo-McCoy; Natali A Minassian; Qumber Jafri; Deng Pan; Jill Kohler; Padmapriya Kumaraswamy; Kenji Kozuka; Jason G Lewis; Dean Dragoli; David P Rosenbaum; Debbie O'Neill; Allein Plain; Peter J Greasley; Ann-Cathrine Jönsson-Rylander; Daniel Karlsson; Margareta Behrendt; Maria Strömstedt; Tina Ryden-Bergsten; Thomas Knöpfel; Eva M Pastor Arroyo; Nati Hernando; Joanne Marks; Mark Donowitz; Carsten A Wagner; R Todd Alexander; Jeremy S Caldwell
Journal:  Sci Transl Med       Date:  2018-08-29       Impact factor: 17.956

Review 10.  Phosphate Metabolism in Health and Disease.

Authors:  Munro Peacock
Journal:  Calcif Tissue Int       Date:  2020-04-07       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.